Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9257 |
High Similarity |
NPD37 |
Approved |
0.9073 |
High Similarity |
NPD4965 |
Approved |
0.9073 |
High Similarity |
NPD4966 |
Approved |
0.9073 |
High Similarity |
NPD4967 |
Phase 2 |
0.8831 |
High Similarity |
NPD6234 |
Discontinued |
0.8718 |
High Similarity |
NPD7199 |
Phase 2 |
0.8562 |
High Similarity |
NPD7228 |
Approved |
0.8491 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.8242 |
Intermediate Similarity |
NPD7240 |
Approved |
0.8221 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8182 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.8069 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8049 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8014 |
Intermediate Similarity |
NPD3705 |
Approved |
0.8012 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7987 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7952 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7904 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7844 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7812 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7811 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7778 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7765 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7751 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.773 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7716 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7706 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7669 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7667 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7667 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7665 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7665 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7665 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7661 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7654 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7654 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7654 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7654 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7636 |
Intermediate Similarity |
NPD5494 |
Approved |
0.763 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7613 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7578 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7568 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7568 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7562 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7548 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7546 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7545 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7532 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7532 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7517 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7484 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7484 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7484 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7471 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7469 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7452 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7439 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7431 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7427 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7421 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7415 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7415 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.741 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.74 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7396 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7386 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7383 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7376 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7375 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7355 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7347 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7342 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7342 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7342 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7341 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD1512 |
Approved |
0.732 |
Intermediate Similarity |
NPD1240 |
Approved |
0.732 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.731 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7308 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7303 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7297 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7262 |
Intermediate Similarity |
NPD919 |
Approved |
0.7261 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7244 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7237 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7233 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7222 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7208 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7208 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7205 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7202 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7197 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7195 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7195 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7186 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7186 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7176 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7172 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7169 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7162 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7162 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7161 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7152 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7151 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.7151 |
Intermediate Similarity |
NPD6842 |
Approved |
0.7151 |
Intermediate Similarity |
NPD6841 |
Approved |
0.7127 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7125 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7119 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7119 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7114 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7108 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7107 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7105 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7101 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7089 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7086 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7081 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7078 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7078 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7073 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7067 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7067 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7044 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7044 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7044 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7041 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7039 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7025 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7019 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7018 |
Intermediate Similarity |
NPD6746 |
Phase 2 |
0.7016 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7007 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7006 |
Intermediate Similarity |
NPD5089 |
Approved |
0.7006 |
Intermediate Similarity |
NPD5090 |
Approved |
0.7 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.6994 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6994 |
Remote Similarity |
NPD5242 |
Approved |
0.6988 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6987 |
Remote Similarity |
NPD943 |
Approved |
0.6982 |
Remote Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.6981 |
Remote Similarity |
NPD3539 |
Phase 1 |
0.6975 |
Remote Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD5005 |
Approved |
0.6968 |
Remote Similarity |
NPD5006 |
Approved |
0.6957 |
Remote Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD2800 |
Approved |
0.6954 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.6951 |
Remote Similarity |
NPD5401 |
Approved |
0.6951 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6951 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6943 |
Remote Similarity |
NPD1933 |
Approved |
0.6943 |
Remote Similarity |
NPD447 |
Suspended |
0.694 |
Remote Similarity |
NPD7296 |
Approved |
0.6936 |
Remote Similarity |
NPD5710 |
Approved |
0.6936 |
Remote Similarity |
NPD5711 |
Approved |
0.6923 |
Remote Similarity |
NPD2978 |
Approved |
0.6923 |
Remote Similarity |
NPD2977 |
Approved |
0.6923 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6923 |
Remote Similarity |
NPD5563 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD4108 |
Discontinued |
0.6914 |
Remote Similarity |
NPD7003 |
Approved |
0.6913 |
Remote Similarity |
NPD4626 |
Approved |
0.6913 |
Remote Similarity |
NPD17 |
Approved |
0.6908 |
Remote Similarity |
NPD1876 |
Approved |
0.6907 |
Remote Similarity |
NPD7827 |
Phase 1 |
0.6899 |
Remote Similarity |
NPD6653 |
Approved |
0.6899 |
Remote Similarity |
NPD6651 |
Approved |
0.6886 |
Remote Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.6886
|
Remote Similarity |
NPD3226 |
Approved |